Defining p53 pioneering capabilities with competitive nucleosome binding assaysXinyang Yu(University at Buffalo, State University of New York), Michael Buck(University at Buffalo, State University of New York)bioRxiv (Cold Spring Harbor Laboratory)May 25, 201810.1101/327635Cited by 1SaveCiteExport RISWatch citationsRelated PapersAlbumin-recruiting lipid nanoparticle potentiates the safety and efficacy of mRNA vaccines by avoiding liver accumulation|Nature Materials|2025|36A substitution at the cytoplasmic tail of the spike protein enhances SARS-CoV-2 infectivity and immunogenicity|EBioMedicine|2024|3Author Correction: Albumin-recruiting lipid nanoparticle potentiates the safety and efficacy of mRNA vaccines by avoiding liver accumulation|Nature Materials|2025|1